Wednesday, May 22, 2013 Last update: 10:04 AM
Company Tech News as it Breaks
Trade Events
Synta Pharmaceuticals Corp.
News articles for Synta Pharmaceuticals Corp.:
Wednesday, May 15, 2013
- Synta Announces Presentations at the 2013 American Society for Clinical Oncology (ASCO) Annual MeetingSynta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced scheduled presentations at the 2013 American Society for Clinical Oncology (ASCO) Annual Meeting, which is taking place May 31 – June ... read more
Tuesday, April 30, 2013
- Synta Provides Clinical Updates and Reports First Quarter 2013 Financial ResultsSynta Pharmaceuticals Corp. (NASDAQ: SNTA) today provided clinical updates and reported financial results for the first quarter ended March 31, 2013. ... read more
Monday, April 22, 2013
- Synta Announces First Patients Treated in Pivotal GALAXY-2 Trial Evaluating Ganetespib in Advanced Non-Small Cell Lung CancerSynta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that the first patients have been treated in the randomized GALAXY-2 Phase 3 trial designed to evaluate docetaxel plus ganetespib, its ... read more
Tuesday, April 16, 2013
- Synta to Host Conference Call and Webcast of First Quarter 2013 Financial Results on April 30, 2013Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will release its first quarter 2013 financial results before the market opens on Tuesday, April 30, 2013. ... read more
Friday, April 5, 2013
- Synta Announces Presentations at the 2013 Annual Meeting of the American Association of Cancer ResearchSynta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that poster presentations related to studies with ganetespib, a selective Hsp90 inhibitor in clinical development by the company, will be presented ... read more
Thursday, March 14, 2013
- Synta Provides Company Updates and Reports Fourth Quarter and Year-End 2012 Financial ResultsSynta Pharmaceuticals Corp. (NASDAQ: SNTA) today provided an update on recent progress with its clinical programs and reported financial results for the fourth quarter and year ended December ... read more
Wednesday, March 13, 2013
- Synta Announces Appointment of Sumant Ramachandra, M.D., Ph.D. as President, Research and DevelopmentSynta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced the appointment of Dr. Sumant Ramachandra as President, Research and Development. ... read more
Monday, February 25, 2013
- Synta to Host Conference Call and Webcast of Fourth Quarter and Year-End 2012 Financial Results on March 14, 2013Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will release its fourth quarter and year-end 2012 financial results before the market opens on Thursday, March 14, 2013. ... read more
Monday, February 11, 2013
- Synta to Present at Upcoming ConferencesSynta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the following investor conferences: Leerink ... read more
Thursday, December 13, 2012
- Synta Pharmaceuticals Announces $60 Million Registered Direct Common Stock OfferingSynta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that it has entered into common stock purchase agreements with members of its Board of Directors and various institutional investors for ... read more
Tuesday, November 27, 2012
- Synta to Present at the Deutsche Bank 2012 dbAccess BioFESTSynta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3 at 10:45 a.m. (EST) in ... read more
Monday, November 26, 2012
- Interim Results of the Phase 2b/3 GALAXY Trial to be Presented at the Fifth Asia Pacific Lung Cancer ConferenceSynta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that interim results of the Phase 2b portion of the GALAXY program will be presented on November 28, 2012 at 12:15 ... read more